ArticleScientific reports2025
A prospective longitudinal study of the changes in multidimensional fatigue and its associated factors in patients undergoing brachytherapy for cervical cancer.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The changes of multidimensional fatigue and associated factors in patients undergoing brachytherapy for cervical cancer are unknown. This study aimed to evaluate changes in multidimensional fatigue with associated factors during and one month after the brachytherapy. This prospective longitudinal study recruited 188 patients undergoing brachytherapy for cervical cancer. They were assessed before the brachytherapy began (T0), after three sessions of brachytherapy (T1), after five sessions of brachytherapy (T2), one month after the whole brachytherapy (T3). Generalized estimating equation analysis was used to determine the factors associated with changes in multidimensional fatigue over time. In this study, total fatigue and five dimensions slightly increased from T0 to T2, with the lowest levels observed at T3. Anxiety, depression, and multidimensional fatigue showed statistically significant differences between T3 and T0, T1, T2. Family adaptability and cohesion showed non-significant changes across four time points. Participants who were older and had more severe anxiety and depression were more likely to experience worse total fatigue (β = 0.084, 0.509, 0.596, respectively), physical fatigue (β = 0.025, 0.078, 0.126, respectively), and reduced motivation (β = 0.027, 0.092, 0.104, respectively). Participants with more severe anxiety and depression were more likely to experience worse general fatigue (β = 0.144 and 0.144, respectively), mental fatigue (β = 0.107 and 0.112, respectively), and reduced activity (β = 0.087 and 0.110, respectively). Older age, more severe anxiety and depression, were significantly associated with worse multidimensional fatigue in patients undergoing brachytherapy for cervical cancer. Healthcare professionals need to continuously monitor multidimensional fatigue, anxiety, and depression during and after brachytherapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.